Brassinin
Axon 2489
CAS [105748-59-2]
MF C11H12N2S2MW 236.36
- Purity:98%
- Soluble in DMSO
Description
Bioavailable dithiocarbamate with affinity for indoleamine 2,3-dioxygenase (IDO; Ki value 28 μM for human IDO) showing antifungal and anticancer activity. Moreover, Brassinin suppressed both constitutive and IL-6-inducible STAT3 activation through modulation of PIAS-3 and SOCS-3, thereby attenuating tumor growth and increasing sensitivity to paclitaxel.
KEYWORDS: Brassinin | supplier | Dual IDO1/STAT3 inhibitor | CAS [105748-59-2] | L-Kynurenine | IDO1 | STAT3 | Inhibitor | IL-6 | PIAS-3 | SOCS-3 | antifungal | anticancer | natural | dithiocarbamate | paclitaxel
| T. Banerjee et al. A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase. Oncogene. 2008 May 1;27(20):2851-7. |
| P. Gaspari et al. Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors. J Med Chem. 2006 Jan 26;49(2):684-92. |
| J.H. Lee et al. Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel. Oncotarget. 2015 Mar 20;6(8):6386-405. |
- Certificate of Analysis
- Material Safety Data Sheet
Chemical name
methyl (1H-indol-3-yl)methylcarbamodithioate
Parent CAS No.
[105748-59-2]
Axon Medchem的业务之一，是独有的Axon Ligands配体库，在世界范围内，被认为是药物研发的标准。这其中，针对850余种生物靶标（包括细胞信号、基因转录、凋亡、细胞周期调控、CNS等），Axon Medchem拥有多达2000余种小分子抑制剂或调节剂。除了配体库，Axon Medchem还是欧洲著名的CRO公司，主要针对生物活性分子和药物类似分子展开合成及协议开发工作，在过去的10年中，Axon Medchem已经发现了多种潜在药物分子，并在生物医药界享有一定的声誉。
暂无问答
本网站将在规定时间内给予删除等相关处理。
